REFERENCES
- Rovee DT, Linsky CB, Bothwell JW. Experimental models for the evaluation of wound repair. In: Animal Models in Dermatology, Maibach HI, ed. New York: Churchill Livingstone; 1975:253–266.
- Davis PH, Hegde IC. The flora of Turkey, present and future. Candollea, Optima Leaflets. 1975;30:331–351.
- Hill AF. Economic Botany: A Textbook of Useful Plants and Products, 2nd ed. New York: McGraw-Hill; 1952:151–174.
- Tyler VE, Brady LR, Robbers JE. Pharmacognosy, 9th ed. Philadelphia, PA: Lea & Febiger; 1988:139–155.
- Duru ME, Çakır A, Harmandar M. Composition of the volatile oils isolated from the leaves of Liquidambar orientalis Mill. var. orientalis and L. orientalis var. integriloba from Turkey. Flav Fragrl J. 2002;17:95–98.
- Sağdiç O, Ozkan G, Ozcan M, A study on inhibitory effects of Siğla tree (Liquidambar orientalis Mill. var. orientalis) storax against several bacteria. Phytother Res. 2005;19:549–551.
- Baytop T. Sur le Styrax liquidus. Pharm Acta Helvetiae. 1950;25:60–63.
- Edwards CA, O'Brien WD Jr. Modified assay for determination of hydroxyproline in a tissue hydrolyzate. Clin Chim Acta. 1980;104:161–167.
- Pirone LA, Bolton LL, Monte KA, Effect of calcium alginate dressings on partial-thickness wounds in swine. J Invest Surg. 1992;5:149–153.
- Pandit A, Ashar R, Feldman D. The effect of TGF-β delivered through a collagen scaffold on wound healing. J Invest Surg. 1999;12:89–100.
- Hafizoglu H. Analytical studies on the balsam of Liquidambar orientalis Mill. by gas chromatography and mass spectrometry. Holzforschung. 1982;36:311–313.
- Hafızoglu H, Reunanen M, Istek A. Chemical composition of levant storax. Holzforschung. 1996;50:116–117.
- Khan IA, Abourashed EA. Leung's Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics, 3rd ed. New Jersey, NJ: Wiley; 2010:1–635.
- Mani H, Sidhu GS, Singh AK. Enhancement of wound healing by shikonin analogue 93/637 in normal and impaired healing. Skin Pharmacol Physiol. 2004;17:49–56.
- Stanford W, Rappole BW, Fox CL Jr. Clinical experience with silver sulfadiazine, a new topical agent for control of pseudomonas infections in burns. J Trauma. 1969;9:377–388.
- Lloyd JR. Improved management of skin graft donor sites. Arch Surg. 1974;108:561–565.
- Ballin JC. Evaluation of a new topical agent for burn therapy: silver sulfadiazine (Silvadene). JAMA. 1974;230:1184– 1185.
- Fox CL. Topical therapy and the development of silver sulfadiazine. Surg Gynecol Obstet. 1983;157:82–88.
- Klasen HJ. A historical review of the use of silver in the treatment of burns: II. Renewed interest for silver. Burns. 2000;26:131–138.
- McCauley RL, Li YY, Poole B, Differential inhibition of human basal keratinocyte growth to silver sulfadiazine and mafenide acetate. J Surg Res. 1992;52:276–285.
- Geronemus RG, Mertz PM, Eaglstein WH. Wound healing: the effects of topical antimicrobial agents. Arch Dermatol. 1979;115:1311–1314.
- Kjolseth D, Frank JM, Barker JH, Comparison of the effects of commonly used wound agents on epithelialization and neovascularization. J Am Coll Surg. 1994;179:305–312.
- Winter GD. Formation of the scab and the rate of epithelialization of superficial wounds in the skin of the young domestic pig. Nature. 1962;193:293–294.
- Hinman CD, Maibach H. Effect of air exposure and occlusion on experimental human skin wounds. Nature. 1963;200:377–378.
- Hermans MH, Hermans RP. Duoderm, an alternative dressing for smaller burns. Burns Incl Therm Inj. 1986;12:214–219.
- Alvarez OM, Mertz PM, Eaglstein WH. The effect of occlusive dressings on collagen synthesis and re-epithelialization in superficial wounds. J Surg Res. 1983;35: 142–148.
- Brennan SS, Foster ME, Leaper DJ. A study of microangiogenesis in wounds healing by secondary intention. Microcirc Endoth Lymph. 1984;1:657–669.